Penelope N. Markham
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
1997First federal award
$2.5MFederal grants as PI11 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
11 awards · $2.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 1, 2003 | NIH | NIH U01 PTE-based drug for antibiotic-resistant anthrax | $676K | — |
| Sep 1, 2003 | NIH | NIH U01 PTE-based drug for antibiotic-resistant anthrax | $73K | — |
| May 1, 2003 | NIH | SBIR/STTR Phase I Bactericidal agents for slow-growing bacteria | $48K | — |
| May 1, 2003 | NIH | SBIR/STTR Phase I Bactericidal agents for slow-growing bacteria | $78K | — |
| Mar 1, 2001 | NIH | SBIR/STTR Phase I EFFLUX INHIBITORS FOR MYCOBACTERIUM THERAPIES | $100K | — |
| Jul 1, 2000 | NIH | SBIR/STTR Phase I POTENTIATORS OF BACTERIOSTATIC ANTIBIOTICS IN GRAM + | $185K | — |
| Sep 1, 1999 | NIH | SBIR/STTR Phase II Potentiators of fluconazole activity in Candida | $382K | — |
| Sep 1, 1999 | NIH | SBIR/STTR Phase II Potentiators of fluconazole activity in Candida | $45K | — |
| Sep 1, 1999 | NIH | SBIR/STTR Phase II Potentiators of fluconazole activity in Candida | $444K | — |
| Sep 1, 1999 | NIH | SBIR/STTR Phase I POTENTIATORS OF FLUCONAZOLE ACTIVITY IN CANDIDA | $100K | — |
| Sep 30, 1997 | NIH | SBIR/STTR Phase II INHIBITORS OF FLUOROQUINOLONE EFFLUX IN GRAM + PATHOGENS | $347K | — |
Peer ranks
Federal funding#181
Awards as PI#51
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.